Description
This product is an antibody binding to human CD274 (PD-L1). The antibody was derived from a hybridoma cell line with high affinity to the recombinant CD274 protein. This monoclonal antibody has been found to inhibit the PD-1/PD-L1 signaling pathway. This product was expressed in a mammalian system, purified by affinity purification, and went through strict quality control. It could be used in immunoassays and research of cancer immunotherapy.
Target
CD274
Isotype/Mimetic
Human IgG4
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression